Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae
- PMID: 30853830
- PMCID: PMC6402341
- DOI: 10.1055/s-0038-1660818
Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae
Abstract
Otitis media (OM) is one of the most common diseases of childhood, and nontypeable Haemophilus influenzae (NTHI) is the predominant causative agent of chronic and recurrent OM, as well as OM for which treatment has failed. Moreover, NTHI is now as important a causative agent of acute OM as the pneumococcus. NTHI colonizes the human nasopharynx asymptomatically. However, upon perturbation of the innate and physical defenses of the airway by upper respiratory tract viral infection, NTHI can replicate, ascend the Eustachian tube, gain access to the normally sterile middle ear space, and cause disease. Bacterial biofilms within the middle ear, including those formed by NTHI, contribute to the chronic and recurrent nature of this disease. These multicomponent structures are highly resistant to clearance by host defenses and elimination by traditional antimicrobial therapies. Herein, we review several strategies utilized by NTHI in order to persist within the human host and interventions currently under investigation to prevent and/or resolve NTHI-induced diseases of the middle ear and uppermost airway.
Keywords: DNABII proteins; EPS; PilA; Type IV pilus; eDNA; integration host factor; phasevarion.
Conflict of interest statement
Competing interest LAN, KLB, EMM and JAJ have no competing interests. LOB is a Scientific Advisor to, and has equity in, ProclaRx, LLC, to whom technology related to the DNABII proteins is licensed. LOB is an inventor of technology related to PilA-derived immunogens which is licensed to GlaxoSmithKline Biologicals.
Figures
References
-
- Pichichero ME. Otitis media. Pediatric clinics of North America. April 2013;60(2):391–407. - PubMed
-
- Baldwin RL. Effects of otitis media on child development. The American journal of otology. November 1993;14(6):601–604. - PubMed
-
- Hunter LL, Margolis RH, Giebink GS. Identification of hearing loss in children with otitis media. Ann Otol Rhinol Laryngol Suppl. May 1994;163:59–61. - PubMed
-
- Johnson DL, McCormick DP, Baldwin CD. Early middle ear effusion and language at age seven. J Commun Disord. Jan-Feb 2008;41(1):20–32. - PubMed
-
- Li SF, Kumar A, Thomas S, et al. Safety and efficacy of intravenous combination sedatives in the ED. The American journal of emergency medicine. September 2013;31(9):1402–1404. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources